The NxStage System One is designed as a simple and practical option for patients to perform hemodialysis therapy in the comfort of their own home.
Many healthcare professionals recognize the limitations of traditional in-center therapy, and accept that more frequent home hemodialysis may improve quality of life, patient outcomes, and survival.1-3 More than 90% of Nephrologists said they would choose a home dialysis therapy for themselves if informed they needed renal replacement therapy, with home hemodialysis being the preferred option.4
More frequent hemodialysis can offer patients access to life-changing benefits. Whether patients are new to dialysis or need to transition from their existing therapy, NxStage can help. Providing patient education on the types of therapies available can help you and your patients select the modality that fits their life and lifestyle.
By working together to explain all the modalities available to your patients including more frequent home hemodialysis, we can improve lifestyles and clinical outcomes for the growing number of dialysis patients today.
- Finkelstein FO, Schiller B, Daoui R, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int. 2012;82(5):561-569.
- FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24):2287-2300.
- Weinhandl ED, Lie J, Gilbertson DT, Arneson TJ, Collins AJ. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23(5):895-904.
- Merighi JR, Schatell DR, Bragg-Gresham JL, Witten B, Mehrotra R. Insights into nephrologist training, clinical practice, and dialysis choice. Hemodial Int. 2012;16(2):242-251.